Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond

Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together 15 IMI consortium projects working on neurodegenerative disease (such as Alzheimer’s), encompassing over EUR 290 million in research funding. The Neuronet programme held four parallel sessions as part of the Alzheimer Europe conference on 24 and 25 October. This involved…

Interview with Lynne Hughes

Lynne Hughes, VP and head of medical CNS strategy at IQVIA, talked about EPAD accomplishments and challenges in an interview article. She provided insights on how EPAD and IQVIA are contributing to advance Alzheimer’s disease research. EPAD is celebrating five years since its inception. What has it accomplished? We have 23 European sites enrolling subjects…

The Neuronet Coordination and Support Action on neurodegeneration research launches its website

The Neuronet (Efficiently Networking European Neurodegeneration Research) communication team is proud to announce the launch of the official project website: http://imi-neuronet.org/ Neuronet is a three-year coordination and support action that kicked off in March 2019.  The aim of Neuronet is to set up an efficient platform to boost collaboration across research projects focusing on neurodegenerative…

EPAD exhibits at AAIC

Members of the EPAD team attended the Alzheimer’s Association International Conference (AAIC) held on 14-18 July. They travelled to Los Angeles (US) from across Europe for the biggest event in dementia research. The event featured a number of key symposia, focused topic sessions and poster presentations and highlighted significant progress, results and theories that will help…

Interview with Christine Trombert

What is your current role in EPAD? Within the Geneva University, I act as a project manager for both EPAD and the AMYPAD Prognostic Natural History Study (PNHS). This includes all the tasks incumbent to this function, ranging from the submissions to the Ethics committee, the follow up of the speed of recruitment, the identification of some deviations…

Interview with Mauro Sousa

What is your current role in EPAD?  I am a Project Manager at IXICO plc, and I manage the delivery of Magnetic Resonance Imaging (MRI) analysis results on EPAD Longitudinal Cohort Study. IXICO data analysis algorithms quantitatively analyse brain scans, to maximise the information extracted and increase chances of detecting therapy-induced changes in clinical trials.…

Spotlight on North Bristol NHS Trust

This month, we get to know the North Bristol centre behind EPAD. The team of Elizabeth Coulthard (principal investigator of the EPAD project in North Bristol) began recruiting in June 2018 and has currently recruited 40 participants in the EPAD Longitudinal Cohort Study (LCS). We caught up with her team and asked them a few…